PlainPharmaWatch

CMS Open Payments · Tool

Trevena, Inc. vs Pharmaceutical Business Consultants Limited

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Trevena, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 7,689, versus 2,034 for the other company. Its single largest recorded recipient represents 0.9% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Trevena, Inc.
HHI 7,689 · top recipient 0.9%
Ranked #201 of 1,838 companies by HHI
Pharmaceutical Business Consultants Limited
HHI 2,034 · top recipient 0.3%
Ranked #746 of 1,838 companies by HHI

Payment Overview

Company A

Trevena, Inc.

Total Payments
$59.3K
% of Industry
0.0%
Transactions
52
Avg per Transaction
$1.1K
Recipients
52
Avg per Recipient
$1.1K
Payment Types
3
Top Payment Type
Consulting Fee
Total Payments
$59.4K
% of Industry
0.0%
Transactions
43
Avg per Transaction
$1.4K
Recipients
43
Avg per Recipient
$1.4K
Payment Types
4
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Trevena, Inc. vs Pharmaceutical Business Consultants Limited - total reported payments in CMS Open Payments PY2024

Pharmaceutical Business Con…$59.4KTrevena, Inc.$59.3K

Payment Types Breakdown

Trevena, Inc.

Consulting Fee $55.2K

93.1%

Travel and Lodging $2.9K

4.9%

Food and Beverage $1.2K

2.0%

Pharmaceutical Business Consultants Limited

Consulting Fee $53.7K

90.4%

Travel and Lodging $5.0K

8.4%

Charitable Contribution $400.00

0.7%

Food and Beverage $322.14

0.5%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Trevena, Inc.

  1. 1

    LINDA WASE

    $51,600.00 · 10 txns

  2. 2

    MARK DEMITRACK

    $6,510.85 · 3 txns

  3. 3

    THOMAS DAHLBERG

    $100.50 · 1 txns

  4. 4

    WAYNE WOODARD

    $100.50 · 1 txns

  5. 5

    ERIC INMAN

    $100.50 · 1 txns

Pharmaceutical Business Consultants Limited

  1. 1

    HASSAN L MIR Dr

    $15,247.70 · 10 txns

  2. 2

    JOHN Tracy WATSON Dr

    $13,813.62 · 10 txns

  3. 3

    JOSHUA W HUSTEDT Dr

    $12,250.00 · 4 txns

  4. 4

    LLOYD CHAMPAGNE Dr

    $11,388.77 · 5 txns

  5. 5

    STEVEN L MORAN Dr

    $3,500.00 · 6 txns

Summary Comparison

Metric Trevena, Inc. Pharmaceutical Business Consultants Limited
Total Payments $59.3K $59.4K
% of Industry Total 0.0% 0.0%
Transaction Count 52 43
Avg per Transaction $1.1K $1.4K
Recipient Count 52 43
Avg per Recipient $1.1K $1.4K
Payment Type Count 3 4
Top Payment Type Consulting Fee Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.